Diaceutics - 1HFY23 trading statement - a strong performance
Diaceutics has released its trading statement for the half year to the end of June, ahead of the interim results to be published on 26 September. The company reported revenue growth of 32% YoY and growth in the order book of 43%. Cash and net cash ended the period at £17.9m and the company remains fully funded to execute the growth strategy it announced in January. Diaceutics is becoming the primary commercialisation partner for pharma companies launching precision medicines with 21 of the top 30 global pharma companies as customers of the company and an increasing percentage of recurring revenue generated from the DXRX platform. Diaceutics notes trading in line with management expectations and with sales weighted to the second half we maintain our current forecasts.
Capital Access Group advises companies on effective engagement with investors. Our experienced team offers market-leading access with hard-to-reach investors, including smaller institutions, pension funds and private client fund managers. These under-serviced investors are located not only in London but across the regions of the UK and Europe. We have an unrivalled knowledge of this extensive audience, to whom our published research is distributed, as well as to larger institutions. We offer this service as part of an integrated investor communications strategy to promote a company’s investment story.
Our clients, ranging from AIM to FTSE 100 companies, benefit from our professional, long-term relationships with investors. Not only do we identify and target investors, we contact them directly and relay their views back to clients with analysis, interpretation and advice. This ensures that our clients are in control of their investor engagement. The objective is to improve the reach and engagement with investors, which in turn strengthens the share price.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.